A global shortage of tocilizumab (Actemra®) is forcing some patients with inflammatory conditions to urgently review their treatment with their treating doctor.
Electronic prescription services are currently being rolled out in Australia. How do they work? How secure are they? Will they replace paper prescriptions?
Ixekizumab (Taltz®) is a new treatment option for Australians with ankylosing spondylitis - a chronic form of arthritis that affects the spine and pelvis.
Upadacitinib (Rinvoq®) is a new treatment option now available for adults with moderate to severe RA who can't tolerate methotrexate or don't respond sufficiently to it.
As part of Be Medicinewise Week, Australians are being urged to keep accurate lists of all our medications to avoid harmful interactions and overdoses.